Cytodyn Inc (CYDY)

[ombowstring]

It's really very simple. What matters is the breakdown between deaths in the leronlimab arm and the placebo arm.

There were 87+ deaths in the trial. If 20 were in the LL arm and 67+ in the placebo arm, we good. I don't see how any guesses based on arbitrary statistical analysis is anything but meaningless.

Nader said in the Jan 6 CC, he expected clinical data sometime this month. All in all, the CC was very positive and worth a listen. Link here:

https://www.cytodyn.com/newsroom/press-releases/detail/497/reminder-cytodyn-to-hold-webcast-on-january-6-to-provide